103 related articles for article (PubMed ID: 2647941)
1. Type VII collagen antibody LH 7.2 identifies basement membrane characteristics of thin malignant melanomas.
Kirkham N; Price ML; Gibson B; Leigh IM; Coburn P; Darley CR
J Pathol; 1989 Mar; 157(3):243-7. PubMed ID: 2647941
[TBL] [Abstract][Full Text] [Related]
2. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
Pluot M; Joundi A; Grosshans E
Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
[TBL] [Abstract][Full Text] [Related]
3. [Nevus associated malignant melanomas--diagnostic validation and prognosis].
Stadler R; Garbe C
Hautarzt; 1991 Jul; 42(7):424-9. PubMed ID: 1938395
[TBL] [Abstract][Full Text] [Related]
4. A comparison of antibodies to type VII and type IV collagen laminin and amnion as epidermal basement membrane markers.
Kirkham N; Gibson B; Leigh IM; Price ML
J Pathol; 1989 Sep; 159(1):5-6. PubMed ID: 2681626
[TBL] [Abstract][Full Text] [Related]
5. Human melanocytic naevi. I. Electron microscopy and 3-dimensional computer reconstruction of naevi and basement membrane zone from ultrathin serial sections.
Lea PJ; Pawlowski A
Acta Derm Venereol Suppl (Stockh); 1986; 127():5-15. PubMed ID: 3468728
[TBL] [Abstract][Full Text] [Related]
6. Expression of intercellular adhesion molecule-1 (ICAM-1) in benign naevi and malignant melanomas.
Hansen NL; Ralfkiaer E; Hou-Jensen K; Thomsen K; Drzewiecki KT; Rothlein R; Vejlsgaard GL
Acta Derm Venereol; 1991; 71(1):48-51. PubMed ID: 1676215
[TBL] [Abstract][Full Text] [Related]
7. The extracellular matrix in pigmented skin lesions: an immunohistochemical study.
Van Duinen CM; Fleuren GJ; Bruijn JA
Histopathology; 1994 Jan; 24(1):33-40. PubMed ID: 7511560
[TBL] [Abstract][Full Text] [Related]
8. Adhesion molecule profile and malignancy of melanocytic lesions.
Moretti S; Martini L; Berti E; Pinzi C; Giannotti B
Melanoma Res; 1993 Aug; 3(4):235-9. PubMed ID: 8219755
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of tumour-infiltrating CD4+CD25+FOXP3+ regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases.
Mourmouras V; Fimiani M; Rubegni P; Epistolato MC; Malagnino V; Cardone C; Cosci E; Nisi MC; Miracco C
Br J Dermatol; 2007 Sep; 157(3):531-9. PubMed ID: 17596146
[TBL] [Abstract][Full Text] [Related]
10. Invading squamous cell carcinoma can retain a basal lamina. An immunohistochemical study using a monoclonal antibody to type IV collagen.
Gusterson BA; Warburton MJ; Mitchell D; Kraft N; Hancock WW
Lab Invest; 1984 Jul; 51(1):82-7. PubMed ID: 6737996
[TBL] [Abstract][Full Text] [Related]
11. Structure of basement membranes in malignant melanoma and nevocytic nevi.
Schmoeckel C; Stolz W; Sakai LY; Burgeson RE; Timpl R; Krieg T
J Invest Dermatol; 1989 May; 92(5):663-8. PubMed ID: 2497191
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions].
Lampert A; Thomine E; Lauret P; Hemet J
Ann Pathol; 1993; 13(2):100-7. PubMed ID: 8363667
[TBL] [Abstract][Full Text] [Related]
13. [Unusual and unknown aspect of cutaneous malignant melanoma: minimal deviation malignant melanoma. Retrospective study of 45 cases].
Mérot Y; Mihm MC
Ann Dermatol Venereol; 1985; 112(4):325-36. PubMed ID: 4026131
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value.
Väisänen A; Tuominen H; Kallioinen M; Turpeenniemi-Hujanen T
J Pathol; 1996 Nov; 180(3):283-9. PubMed ID: 8958806
[TBL] [Abstract][Full Text] [Related]
15. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi.
Mirecka J; Korabiowska M; Schauer A
Pol J Pathol; 1995; 46(3):167-72. PubMed ID: 7496736
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of cerbB3 in naevi and malignant melanomas.
Korabiowska M; Mirecka J; Brinck U; Hoefer K; Marx D; Schauer A
Anticancer Res; 1996; 16(1):471-4. PubMed ID: 8615656
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin/catenin complex in benign and malignant melanocytic lesions.
Silye R; Karayiannakis AJ; Syrigos KN; Poole S; van Noorden S; Batchelor W; Regele H; Sega W; Boesmueller H; Krausz T; Pignatelli M
J Pathol; 1998 Dec; 186(4):350-5. PubMed ID: 10209482
[TBL] [Abstract][Full Text] [Related]
18. c-KIT receptor expression in cutaneous malignant melanoma and benign melanotic naevi.
Ohashi A; Funasaka Y; Ueda M; Ichihashi M
Melanoma Res; 1996 Feb; 6(1):25-30. PubMed ID: 8640066
[TBL] [Abstract][Full Text] [Related]
19. [Nevus on nevus. Apropos of 7 case reports, 3 of them associated with other dysplasias, and 1 with an invasive malignant melanoma].
Brufau C; Moran M; Armijo M
Ann Dermatol Venereol; 1986; 113(5):409-18. PubMed ID: 3579111
[TBL] [Abstract][Full Text] [Related]
20. Micro-anatomy related antigen expression in melanocytic lesions.
Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
